Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

RJF

Insight for Raymond James Financial Investors

We've been asking ourselves recently if the market has placed a fair valuation on Raymond James Financial. Let's dive into some of the fundamental values of this Large-Cap Finance company to determine if there might be an opportunity here for value-minded investors.

a Very Low P/E Ratio but Trading Above Its Fair Price:

Raymond James Financial, Inc., a diversified financial services company, provides private client group, capital markets, asset management, banking, and other services to individuals, corporations, and municipalities in the United States, Canada, and Europe. The company belongs to the Finance sector, which has an average price to earnings (P/E) ratio of 15.92 and an average price to book (P/B) ratio of 1.78. In contrast, Raymond James Financial has a trailing 12 month P/E ratio of 15.8 and a P/B ratio of 2.67.

Raymond James Financial has moved 9.6% over the last year compared to 16.6% for the S&P 500 — a difference of -7.0%. Raymond James Financial has a 52 week high of $177.66 and a 52 week low of $117.57.

Strong Revenue Growth but Positive Cash Flows:

2019 2020 2021 2022 2023 2024
Revenue (M) $8,023 $8,168 $9,910 $11,308 $12,992 $14,923
Interest Income (M) $998 $822 $673 $1,203 $2,375 $2,130
Net Margins 13% 10% 14% 13% 13% 14%
Net Income (M) $1,034 $818 $1,403 $1,509 $1,739 $2,068
Depreciation & Amort. (M) $112 $119 $134 $145 $165 $179
Diluted Shares (M) 212 210 212 220 214 209
Earnings Per Share $4.87 $3.9 $6.61 $6.85 $8.13 $9.89
EPS Growth n/a -19.92% 69.49% 3.63% 18.69% 21.65%
Avg. Price $52.14 $49.39 $85.06 $99.39 $111.5 $162.44
P/E Ratio 10.49 12.41 12.49 14.16 13.37 16.02
Free Cash Flow (M) $439 $3,949 $6,573 -$19 -$3,687 $1,950
CAPEX (M) $138 $124 $74 $91 $173 $205
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS